Pharmafile - Sales and Marketing News
AstraZeneca's much anticipated statin Crestor is to go head-to-head on price with Pfizer blockbuster Lipitor in the Netherlands.
A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, still recovering from a generic...
New guidelines on the labelling of medicines have received a cautious welcome from the pharma industry.
GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.
GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with Pharmacia.
Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.
Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.
AstraZeneca faces a major anti-competition investigation after the European Commission accused the company of obstructing competition to its...
The battle to buy Oxford GlycoSciences has intensified following the acquisition of a 10% stake in the company by Celltech.
Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
